SCHEMBL19201628

SCHEMBL19201628

O=C(CO)NCCP(=O)(O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 0.48
PGK2 P07205 1/20 0.48
TYMS P04818 1/20 0.38
LPAR1 Q92633 1/20 0.37
ENO1 P06733 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
BTN3A1 O00481 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
OTC P00480 1/20 0.34
S1PR2 O95136 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13266984 0.79 MEN1 (0.56) PGK1PGK2LPAR1S1PR2S1PR4
SCHEMBL1156656 0.76 ALDH1A1 (0.41) ALDH1A1
SCHEMBL6908706 0.76 ALDH1A1 (0.46) PGK1PGK2LPAR1ALDH1A1GRIN2D
SCHEMBL10285862 0.76 CASP2 (0.53) PGK1PGK2LPAR1S1PR2S1PR4
SCHEMBL19988193 0.75 PGK1 (0.52) PGK1PGK2TYMSALDH1A1CA12
SCHEMBL1387175 0.75
SCHEMBL10250795 0.74 PGK1 (0.47) PGK1PGK2LPAR1ENO1ALDH1A1
SCHEMBL9543384 0.73 PGK1 (0.50) PGK1PGK2TYMSALDH1A1S1PR2
SCHEMBL23471139 0.71 MEN1 (0.46) LPAR1ALDH1A1
SCHEMBL28749551 0.71 PGK1 (0.48) PGK1PGK2TYMSALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147502-A1 PHOSPHONATE LINKERS AND THEIR USE TO FACILIATE CELLULAR RETENTION OF COMPOUNDS MERCK SHARP & DOHME LLC (US) 2023-05-11 US disclosed
WO-2017132103-A2 PHOSPHONATE LINKERS AND THEIR USE TO FACILITATE CELLULAR RETENTION OF COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2017-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147502-A1 PHOSPHONATE LINKERS AND THEIR USE TO FACILIATE CELLULAR RETENTION OF COMPOUNDS PHOSPHO1, SLC46A1, SLC19A1 PGK1 251/4885PGK2 245/4885TYMS 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.